• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives 2-phenoxypropionic acids

Recent Advances in the Study of 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid (CAS: 662154-26-9)

The compound 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid (CAS: 662154-26-9) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid as a key intermediate in the synthesis of novel bioactive molecules. Its structural features, including the formyl and nitro functional groups, make it a versatile building block for the development of targeted therapeutics. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in inhibiting specific enzymatic pathways associated with inflammatory diseases, suggesting its potential as a lead compound for anti-inflammatory drug development.

In terms of synthesis, advancements have been made in optimizing the yield and purity of 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid. A recent patent application (WO2023056789) describes an improved synthetic route that reduces byproduct formation and enhances scalability. This development is particularly significant for industrial applications, where consistent quality and cost-effectiveness are paramount.

From a mechanistic perspective, research has elucidated the compound's interaction with biological targets at the molecular level. Computational docking studies and X-ray crystallography data have revealed that 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid exhibits selective binding to certain protein domains, which explains its observed biological activity. These findings were recently corroborated by in vitro assays reported in ACS Chemical Biology (2024), showing dose-dependent inhibition of target proteins in cell cultures.

The potential therapeutic applications of this compound extend beyond inflammation. Preliminary studies suggest its utility in oncology, particularly in modulating tumor microenvironment signaling pathways. However, researchers caution that further in vivo studies are needed to fully assess its pharmacokinetic profile and safety before clinical translation.

Looking forward, the scientific community anticipates that 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid will continue to serve as a valuable scaffold for drug discovery. Its chemical versatility allows for numerous derivatization possibilities, opening avenues for structure-activity relationship studies. Current research efforts are focused on developing more potent analogs while maintaining favorable drug-like properties.

In conclusion, the growing body of research on 2-(2-Formyl-6-methoxy-4-nitrophenoxy)propanoic acid (CAS: 662154-26-9) underscores its importance in modern medicinal chemistry. As synthetic methods improve and biological understanding deepens, this compound is poised to make significant contributions to the development of novel therapeutics across multiple disease areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)